Bröske Ann-Marie - Roche Pharma Research and Early Development, Roche Innovation Center Munich

基本信息

浏览量：11

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 21 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Investigating the Complex Interplay Between Fibroblast Activation Protein Α-Positive Cancer Associated Fibroblasts and the Tumor Microenvironment in the Context of Cancer Immunotherapy

Anton Kraxner,Franziska Braun,Wei-Yi Cheng,Tai-Hsien Ou Yang, Shweta Pipaliya,Marta Canamero,Emilia Andersson,Suzana Vega Harring,Sebastian Dziadek,Ann-Marie E. Broeske,Maurizio Ceppi,Tamara Tanos,Volker Teichgraber,Jehad Charo

FRONTIERS IN IMMUNOLOGY (2024)

引用0浏览0WOS引用

Comprehensive Analysis of Fibroblast Activation Protein Expression Across 23 Tumor Indications: Insights for Biomarker Development in Cancer Immunotherapies

Sebastian Dziadek,Anton Kraxner,Wei-Yi Cheng,Tai-Hsien Ou Yang, Mike Flores,Noah Theiss,Tsu-Shuen Tsao,Emilia Andersson,Suzana Vega Harring,Ann-Marie E. Broeske,Maurizio Ceppi,Volker Teichgraeber,Jehad Charo

FRONTIERS IN IMMUNOLOGY (2024)

引用0浏览0WOS引用

Molecular Mechanisms Underlying Response and Resistance to Glofitamab

Sina Nassiri,Stephan Schmeing,Gabrielle Leclercq,Sylvia Herter,Llucia Alberti Servera,Tamara Hüsser,Emilio Yángüez,Diana Dunshee,Koorosh Korfi,Pablo Umana,Ann-Marie E. Bröske,Alessia Bottos,Marina Bacac

Blood (2023): 1619

引用0浏览0引用

Co-Expression of GPRC5D, FcRH5 and BCMA Suggests That Targeting More Than One Cell Surface Marker May Be a Viable Strategy in Relapsed/Refractory Multiple Myeloma (RRMM): Biomarker Results from the Phase I Study of Forimtamig, a GPRC5DxCD3 Bispecific Antibody

Iryna Dekhtiarenko,Iva Lelios,Wolfgang Jacob,Meike Schneider,Martin Weisser,Carmelo Carlo-Stella,Salomon Manier,Simon J. Harrison,Rakesh Popat,Anna Caroline Hasselbalch Riley,Ann-Marie E. Broeke

Blood（2023）

引用0浏览0引用

RG6234, a GPRC5DxCD3 T-Cell Engaging Bispecific Antibody, is Highly Active in Patients (pts) with Relapsed/Refractory Multiple Myeloma (RRMM): Updated Intravenous (IV) and First Subcutaneous (SC) Results from a Phase I Dose-Escalation Study

Blood（2022）

引用17浏览0引用

Intravenous and Subcutaneous Administration of RG6234, a Novel GPRC5DxCD3 T-Cell Engaging Bispecific Antibody, is Highly Active in Patients with Relapsed/Refractory Multiple Myeloma (RRMM): Biomarker Results from a Phase I Study

Iryna Dekhtiarenko,Iva Lelios,Jan Attig,Nassim Sleiman, Domenico Lazzaro,Emilie Schindler,Jan Eckmann,Pablo Umana,Wolfgang Jacob,Meike Schneider,Carmelo Carlo-Stella,Rita Mazza,Salomon Manier,Thierry Facon,Sung-Soo Yoon,Youngil Koh,Simon J. Harrison,Jeremy Er,Antonio Pinto,Francesco Volzone,Giulia Perrone,Paolo Corradini,Titouan Cazaubiel, Cyrille Hulin,Cyrille Touzeau, Philippe Moreau, Enrique M. Ocio, Carmen Maria Montes Gaisan,Rakesh Popat,Sarah Leong,Fritz Offner,Paula Rodriguez Otero,Ana Alfonso-Pierola, Martin Hutchings,Caroline Hasselbalch Riley,Ann-Marie E. Broske

Blood（2022）

引用3浏览0引用

Pharmacodynamics and Molecular Correlates of Response to Glofitamab in Relapsed/refractory Non-Hodgkin Lymphoma

Ann-Marie E. Broeske,Koorosh Korfi,Anton Belousov,Sabine Wilson,Chia-Huey Ooi,Christopher R. Bolen,Marta Canamero, Enrique Gomez Alcaide, Ian James,Emily C. Piccione,David J. Carlile,Natalie Dimier,Pablo Umana,Marina Bacac,Martin Weisser,Michael Dickinson

Blood advances（2022）

引用20浏览0WOS引用

Novel 17-Plex Flow Cytometry Assay for Comprehensive Immunophenotyping and Characterization of Plasma Cells (PC) in Relapsed/Refractory (RR) Multiple Myeloma (MM) Patients

Iva Lelios, Enrique Gomez,Iryna Dekhtiarenko,Priscila Camillo Teixeira,Ann-Marie E. Broske

Blood（2022）

引用0浏览0引用

Abstract LB558: Single Cell Profiling of PBMCs Reveals Correlates of Clinical Response to Glofitamab

Sina Nassiri, Lucas Habegger,Petra Gerber,Vinko Tosevski,Tamara Hüsser,Emilio Yanguez,Sylvia Herter,Martin Weisser,Koorosh Korfi,Pablo Umana,Emily Piccione,Ann-Marie Bröske,Marina Bacac

Cancer researchno. 12_Supplement (2022): LB558-LB558

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn